NCT00536913 - Evaluation of Safety and Efficacy of Symbicort® pMDI, With or Without Spacer, in Children (6-11 Years) With Asthma | Biotech Hunter

Enrollment

107

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions

Asthma

Interventions

DRUG

Budesonide/formoterol pMDI 40/2.25ug + spacer

DRUG

Budesonide/formoterol pMDI 40/2.25 ug

Trial Locations (11)

Research Site, Budapest

Research Site, Debrecen

Research Site, Kaposvár

Research Site, Bialystok

Research Site, Bydgoszcz

Research Site, Bytom

Research Site, Karpacz

Research Site, Krakow

Research Site, Lodz

Research Site, Warsaw

Research Site, Moscow